In clinically more aggressive primary breast cancers, particularly those with a triple negative phenotype, and in breast cancer metastases, HPGD is overexpressed, with high HPGD expression associated with poor prognosis and reduced survival [18]. This evidence concerns the gene HPGD and breast cancer.